Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2024 Earnings Call Transcript March 27, 2025
Acumen Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.62 EPS, expectations were $-0.47.
Operator: Good day and welcome to Acumen Pharma Fiscal Year 2024 Conference Call and Webcast. At this time all participants are in a listen-only mode. After the speakers’ presentation there will be a question-and-answer session and instructions will be given at that time. As a reminder...
